anmelden
GSK Aktie
21,37
EUR
-0,31
EUR
-1,43
%
18,18
GBP
-0,39
GBP
-2,10
%
GSK jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 87,6 Mrd. EUR
KGV 12,93 Div. Rendite 3,62%WKN A3DMB5
ISIN GB00BN7SWP63
Symbol GLAXF
AI Analyse
Werbung
GSK Aktie Analyse
| 21.10.15 | GSK market-perform | Bernstein Research | |
| 21.10.15 | GSK Neutral | UBS AG | |
| 21.10.15 | GSK buy | Goldman Sachs Group Inc. | |
| 13.10.15 | GSK Neutral | JP Morgan Chase & Co. | |
| 12.10.15 | GSK Hold | Jefferies & Company Inc. | |
| 09.10.15 | GSK neutral | Independent Research GmbH | |
| 18.09.15 | GSK buy | Goldman Sachs Group Inc. | |
| 16.09.15 | GSK Neutral | BNP PARIBAS | |
|
Werbung
|
|||
| 10.09.15 | GSK Hold | Jefferies & Company Inc. | |
| 09.09.15 | GSK Strong Sell | S&P Capital IQ | |
| 09.09.15 | GSK Neutral | Citigroup Corp. | |
| 09.09.15 | GSK buy | Goldman Sachs Group Inc. | |
| 09.09.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.09.15 | GSK Neutral | UBS AG | |
| 21.08.15 | GSK buy | Goldman Sachs Group Inc. | |
| 11.08.15 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.08.15 | GSK Hold | Jefferies & Company Inc. | |
| 07.08.15 | GSK verkaufen | BNP PARIBAS | |
| 04.08.15 | GSK kaufen | Independent Research GmbH | |
| 31.07.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.07.15 | GSK Equal-Weight | Morgan Stanley | |
| 30.07.15 | GSK Hold | Deutsche Bank AG | |
| 30.07.15 | GSK Sell | Société Générale Group S.A. (SG) | |
| 29.07.15 | GSK Sell | S&P Capital IQ | |
| 17.07.15 | GSK buy | Goldman Sachs Group Inc. | |
| 17.07.15 | GSK Neutral | UBS AG | |
| 14.07.15 | GSK overweight | Barclays Capital | |
| 10.07.15 | GSK neutral | Deutsche Bank AG | |
| 26.06.15 | GSK buy | HSBC | |
| 10.06.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.06.15 | GSK Equal-Weight | Morgan Stanley | |
| 26.05.15 | GSK verkaufen | JP Morgan Chase & Co. | |
| 22.05.15 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.05.15 | GSK Hold | Jefferies & Company Inc. | |
| 21.05.15 | GSK neutral | Citigroup Corp. | |
| 20.05.15 | GSK Underperform | Merrill Lynch & Co., Inc. | |
| 14.05.15 | GSK Neutral | UBS AG | |
| 08.05.15 | GSK buy | Goldman Sachs Group Inc. | |
| 07.05.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.05.15 | GSK buy | UBS AG | |
| 06.05.15 | GSK Sell | S&P Capital IQ | |
| 05.05.15 | GSK overweight | Morgan Stanley | |
| 05.05.15 | GSK overweight | Barclays Capital | |
| 01.05.15 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.15 | GSK buy | UBS AG | |
| 29.04.15 | GSK buy | UBS AG | |
| 28.04.15 | GSK buy | Goldman Sachs Group Inc. | |
| 22.04.15 | GSK Underweight | JP Morgan Chase & Co. | |
| 21.04.15 | GSK market-perform | Bernstein Research | |
Werbung
Werbung
